Kura Oncology, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Kura Oncology, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Kura Oncology, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $148M.
  • Kura Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $94.8M, a 146% increase from 2022.
  • Kura Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $38.6M.
  • Kura Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$3.44M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $148M* Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2022 $303K +$224K +284% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $79K -$168K -68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $247K +$145K +142% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $102K -$57.5M -99.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q1 2018 $57.7M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2013 $0 -$25K -100% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 $25K +$25K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.